Las patentes farmacéuticas en razón de la covid-19 desde la perspectiva del law and economics movement.

This paper have by object to clarify the dilemma related with the exploitation monopoly created by pharmaceutical invention patents, which, while incentive the innovation, in turn, represent obstacles to accessing essential medicines, as a patented thing, and therefore, it will be sold at high costs in the market. This affects the enjoyment of the right to health of patients, because it´s products with a few elasticity or near substitutes, and while the patent be valid; No other competitor can carry out, without the authorization of the owner, the acts mentioned in Article 28 of the Trade Related Aspects of Intellectual Property Rights Agreement. [ABSTRACT FROM AUTHOR]